ANTIBODIES TARGETING B-CELL RECEPTOR COMPLEX MEMBRANE BOUND IGM AND USES THEREOF

The present invention relates to antibodies targeting the membrane bound IgM (mlgM) of the B-cell receptor complex found in B-cell lymphomas and leukemias and uses 5 thereof. Another aspect of the present invention is the use of anti-B-Cell mgM antibodies in the treatment of B-cell malignancies, inc...

Full description

Saved in:
Bibliographic Details
Main Authors WELT, Jonathan A, WELT, Rachel S, RAYMOND, Virginia, KOSTYAL, David, WELT, Sydney
Format Patent
LanguageEnglish
Published 03.10.2019
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
ENZYMOLOGY
FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to antibodies targeting the membrane bound IgM (mlgM) of the B-cell receptor complex found in B-cell lymphomas and leukemias and uses 5 thereof. Another aspect of the present invention is the use of anti-B-Cell mgM antibodies in the treatment of B-cell malignancies, including B-cell lymphomas and leukemias.
Bibliography:Application Number: AU20190229346